AIMMUNE THERAPEUTICS INC's ticker is AIMT and the CUSIP is 00900T107. A total of 193 filers reported holding AIMMUNE THERAPEUTICS INC in Q3 2020. The put-call ratio across all filers is 1.23 and the average weighting 0.4%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2020 | $1,192,000 | +11.4% | 34,600 | -46.0% | 0.02% | -5.9% |
| Q2 2020 | $1,070,000 | -7.6% | 64,060 | +15.9% | 0.02% | +70.0% |
| Q3 2019 | $1,158,000 | +276.0% | 55,278 | +300.6% | 0.01% | +233.3% |
| Q1 2019 | $308,000 | -54.2% | 13,800 | -50.9% | 0.00% | -62.5% |
| Q4 2018 | $672,000 | -33.3% | 28,088 | -23.9% | 0.01% | -33.3% |
| Q3 2018 | $1,007,000 | +24.8% | 36,916 | +23.1% | 0.01% | +9.1% |
| Q2 2018 | $807,000 | +7.3% | 30,000 | +50.8% | 0.01% | -15.4% |
| Q4 2017 | $752,000 | – | 19,891 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Palo Alto Investors LP | 3,295,712 | $47,524,000 | 3.98% |
| Samsara BioCapital, LLC | 232,571 | $3,354,000 | 1.93% |
| Eventide Asset Management | 3,851,000 | $55,531,000 | 1.80% |
| Burrage Capital Management LLC | 112,546 | $1,609,000 | 1.58% |
| Avidity Partners Management LP | 408,000 | $5,883,000 | 0.81% |
| RICE HALL JAMES & ASSOCIATES, LLC | 982,484 | $14,167,000 | 0.79% |
| Bullseye Asset Management LLC | 43,374 | $626,000 | 0.75% |
| Nantahala Capital Management | 1,005,302 | $14,496,000 | 0.54% |
| ARMISTICE CAPITAL, LLC | 600,000 | $8,652,000 | 0.54% |
| Values First Advisors, Inc. | 27,042 | $389,947 | 0.47% |